These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32428268)

  • 1. Protein-Templated Hit Identification through an Ugi Four-Component Reaction*.
    Mancini F; Unver MY; Elgaher WAM; Jumde VR; Alhayek A; Lukat P; Herrmann J; Witte MD; Köck M; Blankenfeldt W; Müller R; Hirsch AKH
    Chemistry; 2020 Nov; 26(64):14585-14593. PubMed ID: 32428268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-Templated Ugi Reactions versus In-Situ Ligation Screening: Two Roads to the Identification of SARS-CoV-2 Main Protease Inhibitors.
    Wamser R; Zhang X; Kuropka B; Arkona C; Rademann J
    Chemistry; 2024 Mar; 30(17):e202303940. PubMed ID: 38246870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragment-Based Drug Design Facilitated by Protein-Templated Click Chemistry: Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin.
    Mondal M; Unver MY; Pal A; Bakker M; Berrier SP; Hirsch AK
    Chemistry; 2016 Oct; 22(42):14826-14830. PubMed ID: 27604032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized Inhibitors of MDM2 via an Attempted Protein-Templated Reductive Amination.
    van der Vlag R; Yagiz Unver M; Felicetti T; Twarda-Clapa A; Kassim F; Ermis C; Neochoritis CG; Musielak B; Labuzek B; Dömling A; Holak TA; Hirsch AKH
    ChemMedChem; 2020 Feb; 15(4):370-375. PubMed ID: 31774938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic Target-Guided Synthesis: Reaching the Age of Maturity.
    Bosc D; Camberlein V; Gealageas R; Castillo-Aguilera O; Deprez B; Deprez-Poulain R
    J Med Chem; 2020 Apr; 63(8):3817-3833. PubMed ID: 31820982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of α-amino-1,3-dicarbonyl compounds via Ugi flow chemistry reaction: access to functionalized 1,2,3-triazoles.
    Vasconcelos SNS; Fornari E; Caracelli I; Stefani HA
    Mol Divers; 2017 Nov; 21(4):893-902. PubMed ID: 28702849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-Templated Formation of an Inhibitor of the Blood Coagulation Factor Xa through a Background-Free Amidation Reaction.
    Jaegle M; Steinmetzer T; Rademann J
    Angew Chem Int Ed Engl; 2017 Mar; 56(13):3718-3722. PubMed ID: 28199769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin: Fragment-Based Drug Design Facilitated by Dynamic Combinatorial Chemistry.
    Mondal M; Radeva N; Fanlo-Virgós H; Otto S; Klebe G; Hirsch AK
    Angew Chem Int Ed Engl; 2016 Aug; 55(32):9422-6. PubMed ID: 27400756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic acids as templates and catalysts in chemical reactions: target-guided dynamic combinatorial chemistry and
    Saha P; Panda D; Dash J
    Chem Soc Rev; 2023 Jul; 52(13):4248-4291. PubMed ID: 37306487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propargyl Amines: Versatile Building Blocks in Post-Ugi Transformations.
    Bhoraniya RB; Modha SG
    ChemistryOpen; 2023 Apr; 12(4):e202200223. PubMed ID: 36720775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design of inhibitors of the aspartic protease endothiapepsin by exploiting dynamic combinatorial chemistry.
    Mondal M; Radeva N; Köster H; Park A; Potamitis C; Zervou M; Klebe G; Hirsch AK
    Angew Chem Int Ed Engl; 2014 Mar; 53(12):3259-63. PubMed ID: 24532096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploitation of the Ugi-Joullié reaction in drug discovery and development.
    Gazzotti S; Rainoldi G; Silvani A
    Expert Opin Drug Discov; 2019 Jul; 14(7):639-652. PubMed ID: 31002536
    [No Abstract]   [Full Text] [Related]  

  • 13. Very rapid DNA-templated reaction for efficient signal amplification and its steady-state kinetic analysis of the turnover cycle.
    Shibata A; Uzawa T; Nakashima Y; Ito M; Nakano Y; Shuto S; Ito Y; Abe H
    J Am Chem Soc; 2013 Sep; 135(38):14172-8. PubMed ID: 24015779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ugi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors.
    Brandão P; López Ó; Leitzbach L; Stark H; Fernández-Bolaños JG; Burke AJ; Pineiro M
    ACS Med Chem Lett; 2021 Nov; 12(11):1718-1725. PubMed ID: 34795859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Druggability Assessment of Targets Used in Kinetic Target-Guided Synthesis.
    Unver MY; Gierse RM; Ritchie H; Hirsch AKH
    J Med Chem; 2018 Nov; 61(21):9395-9409. PubMed ID: 29873484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic Imines in Ugi and Ugi-Type Reactions.
    Nazeri MT; Farhid H; Mohammadian R; Shaabani A
    ACS Comb Sci; 2020 Aug; 22(8):361-400. PubMed ID: 32574488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isocyanide Multicomponent Reactions on Solid Phase: State of the Art and Future Application.
    Cankařová N; Krchňák V
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ click chemistry: enzyme inhibitors made to their own specifications.
    Manetsch R; Krasiński A; Radić Z; Raushel J; Taylor P; Sharpless KB; Kolb HC
    J Am Chem Soc; 2004 Oct; 126(40):12809-18. PubMed ID: 15469276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regioselective Cyclic Iminium Formation of Ugi Advanced Intermediates: Rapid Access to 3,4-Dihydropyrazin-2(1
    Cankařová N; Krchňák V
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of highly functionalized organic compounds through Ugi post-transformations started from propiolic acids.
    Mohammadi-Khanaposhtani M; Jalalimanesh N; Saeedi M; Larijani B; Mahdavi M
    Mol Divers; 2020 Aug; 24(3):855-887. PubMed ID: 31325081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.